The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
EAHP in the news – Position paper on BIOSIMILAR MEDICINES
- “La farmacia de hospital europea apoya la sustitución de biosimilares” – Redacción Médica (Spanish)
- EAHP: defiende la sustitución de biológicos por biosimilares- Top Market Acces (Spanish)
- La EAHP defiende la sustitución de biológicos por biosimilares en situaciones previamente pactadas – Diario farma (Spanish)